Ulixertinib

(Synonyms: BVD-523; VRT752271)
52 Cited Publications
고객리뷰

Based on 52 publication(s) in Google Scholar

Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.92%
  • CAS No.: 869886-67-9
  • 화학식: C21H22Cl2N4O2
  • 분자량:433.33
  • 보관:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Ulixertinib

More
Customer Validation & Images
WBCell Migration/Invasion AssayIHCIn Vivo Efficacy Study
  • IHC
  • WB
  • WB
  • Cell Migration/Invasion Assay
  • In Vivo Efficacy Study
  • WB

All ERK Isoforms

More
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00